UMP Healthcare Holdings Limited (HKG:0722)
0.3900
0.00 (0.00%)
Oct 14, 2026, 10:31 AM HKT
UMP Healthcare Holdings Ratios and Metrics
Market cap in millions HKD. Fiscal year is July - June.
Millions HKD. Fiscal year is Jul - Jun.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 13, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
| 313 | 365 | 384 | 416 | 617 | 587 | |
Market Cap Growth | -17.54% | -4.80% | -7.65% | -32.62% | 5.07% | -17.67% |
Enterprise Value | 101 | 182 | 215 | 281 | 487 | 400 |
Last Close Price | 0.39 | 0.46 | 0.45 | 0.45 | 0.61 | 0.56 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 13, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
PE Ratio | - | - | 12.21 | 10.23 | 10.20 | 8.13 |
Forward PE | - | 19.24 | 19.24 | 19.24 | 19.24 | 19.24 |
PS Ratio | 0.44 | 0.51 | 0.53 | 0.55 | 0.85 | 0.88 |
PB Ratio | 0.48 | 0.56 | 0.51 | 0.56 | 0.80 | 0.80 |
P/TBV Ratio | 0.60 | 0.70 | 0.70 | 0.79 | 1.17 | 1.24 |
P/FCF Ratio | - | - | 2.74 | 4.54 | 7.64 | 22.24 |
P/OCF Ratio | - | - | 2.53 | 2.79 | 3.25 | 5.29 |
PEG Ratio | - | 0.18 | 0.18 | 0.18 | 0.18 | 0.18 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 13, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
EV/Sales Ratio | 0.14 | 0.25 | 0.30 | 0.37 | 0.67 | 0.60 |
EV/EBITDA Ratio | 1.43 | 2.56 | 2.63 | 4.08 | 4.69 | 3.93 |
EV/EBIT Ratio | 3.86 | 6.82 | 5.74 | 10.78 | 6.99 | 5.27 |
EV/FCF Ratio | - | - | 1.53 | 3.07 | 6.03 | 15.15 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 13, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Debt / Equity Ratio | 0.22 | 0.22 | 0.22 | 0.23 | 0.22 | 0.20 |
Debt / EBITDA Ratio | 2.02 | 2.02 | 1.13 | 1.23 | 0.99 | 0.94 |
Debt / FCF Ratio | - | - | 1.15 | 1.89 | 2.13 | 5.62 |
Net Debt / Equity Ratio | -0.34 | -0.34 | -0.26 | -0.18 | -0.21 | -0.19 |
Net Debt / EBITDA Ratio | -3.15 | -3.15 | -2.41 | -1.96 | -1.56 | -1.41 |
Net Debt / FCF Ratio | - | - | -1.41 | -1.47 | -2.01 | -5.43 |
Asset Turnover | 0.69 | 0.69 | 0.66 | 0.67 | 0.67 | 0.66 |
Inventory Turnover | 16.36 | 16.36 | 16.12 | 18.66 | 21.23 | 22.43 |
Quick Ratio | 1.95 | 1.95 | 1.92 | 1.73 | 1.76 | 2.15 |
Current Ratio | 2.11 | 2.11 | 2.00 | 1.81 | 1.83 | 2.23 |
Return on Equity (ROE) | -10.36% | -10.36% | 4.27% | 4.65% | 7.40% | 10.35% |
Return on Assets (ROA) | 1.60% | 1.60% | 2.13% | 1.46% | 4.03% | 4.72% |
Return on Invested Capital (ROIC) | 6.25% | 5.45% | 5.08% | 3.71% | 10.04% | 12.79% |
Return on Capital Employed (ROCE) | 3.70% | 3.70% | 4.50% | 3.10% | 8.20% | 9.00% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 13, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Earnings Yield | -23.83% | -20.43% | 8.19% | 9.78% | 9.80% | 12.29% |
FCF Yield | - | - | 36.57% | 22.03% | 13.09% | 4.50% |
Dividend Yield | 7.18% | 6.17% | 6.91% | 6.35% | 6.09% | 6.00% |
Payout Ratio | - | - | 87.70% | 84.56% | 38.22% | 30.54% |
Buyback Yield / Dilution | -0.40% | -0.40% | 1.28% | -1.21% | -2.17% | -1.61% |
Total Shareholder Return | 6.51% | 5.77% | 8.19% | 5.14% | 3.92% | 4.39% |